Your browser doesn't support javascript.
loading
Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients.
Sanoyan, Dilara Akhoundova; Seipel, Katja; Bacher, Ulrike; Kronig, Marie-Noelle; Porret, Naomi; Wiedemann, Gertrud; Daskalakis, Michael; Pabst, Thomas.
Affiliation
  • Sanoyan DA; Department of Medical Oncology, Inselspital, University Hospital of Bern, Center for Hemato-Oncology; University Cancer Center, Bern, 3010, Switzerland.
  • Seipel K; Department for Biomedical Research, University of Bern, Bern, 3008, Switzerland.
  • Bacher U; Department for Biomedical Research, University of Bern, Bern, 3008, Switzerland.
  • Kronig MN; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Porret N; Department of Medical Oncology, Inselspital, University Hospital of Bern, Center for Hemato-Oncology; University Cancer Center, Bern, 3010, Switzerland.
  • Wiedemann G; Clinical Genomics Lab, Inselspital, University Hospital of Bern, Bern, 3010, Switzerland.
  • Daskalakis M; Clinical Genomics Lab, Inselspital, University Hospital of Bern, Bern, 3010, Switzerland.
  • Pabst T; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
BMC Cancer ; 23(1): 345, 2023 Apr 15.
Article in En | MEDLINE | ID: mdl-37061680
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Chimeric Antigen / Multiple Myeloma Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Switzerland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Chimeric Antigen / Multiple Myeloma Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2023 Type: Article Affiliation country: Switzerland